RecallRadar

FDA Drug recall D-202-2013

Venlafaxine Hydrochloride Tablets, 75 mg*, 100-count tablets per bottle, Rx only, Manufactured by: Cadila Healthcare Ltd., Ahmedabad, India

On 2013-04-03 the FDA classified a Class II recall of Venlafaxine Hydrochloride Tablets, 75 mg*, 100-count tablets per bottle, Rx only, Manufactured by: Cadila Healthcare Ltd., Ahmedabad, India by Zydus Pharmaceuticals Usa, citing failed Tablet/Capsule Specifications: Pharmacist complaint of an excessive amount of broken and/or chipped tablets in the bottle.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-202-2013
ClassificationClass II
Statusterminated
Initiated2013-03-05
Published2013-04-03
Last updated2026-09-13 11:51 UTC
CompanyZydus Pharmaceuticals Usa
DistributionUS

Product

Venlafaxine Hydrochloride Tablets, 75 mg*, 100-count tablets per bottle, Rx only, Manufactured by: Cadila Healthcare Ltd., Ahmedabad, India; Distributed by: Zydus Pharmaceuticals USA Inc., Pennington, NJ 08534, NDC 68382-021-01.

Reason

Failed Tablet/Capsule Specifications: Pharmacist complaint of an excessive amount of broken and/or chipped tablets in the bottle.

Identifiers

ndc68382-018-06
ndc68382-018-14
ndc68382-018-16
ndc68382-018-01
ndc68382-018-05
ndc68382-018-10
ndc68382-019-06
ndc68382-019-14
ndc68382-019-16
ndc68382-019-01
ndc68382-019-05
ndc68382-019-10
ndc68382-020-06
ndc68382-020-14
ndc68382-020-16
ndc68382-020-01
ndc68382-020-05
ndc68382-020-10
ndc68382-021-06
ndc68382-021-14
ndc68382-021-16
ndc68382-021-01
ndc68382-021-05
ndc68382-021-10
ndc68382-101-06
ndc68382-101-14
ndc68382-101-16
ndc68382-101-01
ndc68382-101-05
ndc68382-101-10
code_infoLot #: MM8490, Exp 09/14

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-202-2013%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.